WHITEBOX ADVISORS LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITEBOX ADVISORS LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$8,677,750
+1.3%
16,850,000
-4.3%
0.28%
+18.0%
Q2 2023$8,569,440
+5.0%
17,600,000
-14.6%
0.23%
-16.8%
Q1 2023$8,159,660
-22.9%
20,600,000
+5.1%
0.28%
-4.4%
Q4 2022$10,584,000
-0.9%
19,600,0000.0%0.29%
-1.3%
Q3 2022$10,682,000
-1.8%
19,600,000
-2.0%
0.30%
-11.3%
Q2 2022$10,875,000
+2.4%
20,000,000
-4.8%
0.34%
+56.5%
Q1 2022$10,618,000
-9.7%
21,000,000
-6.7%
0.21%
-10.8%
Q4 2021$11,756,00022,500,0000.24%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders